MH Services

This is a request for the following data:

– How many ADHD patients do you have currently?
– What percentage of ADHD patients are prescribed stimulant medication?
– How many ADHD patients have stopped taking stimulant medication since 2020? Please specify how many patients stopped because of side effects they were experiencing and make a brief note of the side effect
– Since 2020 how many ADHD patients were prescribed non-pharmacological treatment? This could include Cognitive Behavioral Therapy, parent of family training, neurofeedback or advice and programs related to mindfulness and yoga. Please specify what the treatment was.

I am writing to request the following information under the Freedom of Information Act 2000.

Please provide data for the period April 2024 to March 2025, broken down by calendar month where applicable as well as planned capital works for the current year 2025/2026. The following request: 1. People in Beds a. Acute Mental Health Placements (Out-of-Trust / Private Sector) • The number of female patients placed in private sector or out-of-trust acute mental health beds each month. • The number of male patients placed in private sector or out-of-trust acute mental health beds each month. b. PICU (Psychiatric Intensive Care Unit) Placements (Out-of-Trust / Private Sector) • The number of female patients placed in private sector or out-of-trust PICU beds each month. • The number of male patients placed in private sector or out-of-trust PICU beds each month. c. Rehabilitation Mental Health Placements • The number of patients placed in rehabilitation mental health placements, broken down by gender (male/female) and by month. 2. Bed Day Costs For the period April 2024 to March 2025, please provide the average daily bed fee paid for private sector placements, broken down by patient gender (if available) and setting: • Acute mental health placements • PICU placements • Rehabilitation placements 3. Placement Locations Please provide the names and addresses (or town/city) of all private sector or out-of-trust facilities where patients (both male and female) were placed in the following settings: • Acute mental health • PICU • Rehabilitation 4. Clinically Ready for Discharge (CRFD) Please provide the number of patients occupying NHS Trust acute mental health beds each month who were deemed clinically ready for discharge but remained in hospital (commonly referred to as Delayed Transfers of Care – DTOC). 5. Planned Capital Improvement Works Please confirm whether there are any planned or ongoing capital improvement works during the period April 2025 – March 2026 that may impact patient flow (e.g. reduction in bed availability, ward closures, reconfigurations). If so, please provide a summary of the works, broken down by service area: • Acute (Adult and Older Adult) • CAMHS (Child and Adolescent Mental Health Services) • Forensic Services • Specialist Services (e.g. Perinatal, Eating Disorders, Neuropsychiatry) T

I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).

The information being requested is as follows:

1. Please provide the number of ECT treatments given to patients for each of the calendar years 2023 & 2024.

2. Please provide the number of people who received the ECT in each of the calendar years 2023 and 2024.

I’d like to request whether you hold any SOPs for the management of Restrictive Intake Self-Harm (RISH) or restricted food in the context of eating disorders or similarly titled SOPS in either your general or acute hospitals.

CAMHS liaison service in Portsmouth (Queen Alexandra Hospital) are hoping to review existing literature to support general hospital colleagues to construct a SOP for supporting this patient group in general hospitals.

The Specialist Treatment and Recovery (STAR) team is a team commissioned by GICB to provide assistance with complex mental health needs that cannot be met by existing commissioned services.

Firstly can you provide all information you have regarding the responsibility, duties and aims of the STAR team? Are they a subsection of the recovery team? What facilities, treatments and resources do they have access to? Are they supposed to interact with patients directly or do they possess a more bureaucratic role or do the members provide treatment themselves?

Secondly can you provide a contact email address for the STAR team.

I am writing to you on behalf of Alzheimer’s Research UK (Registered charity number 1077089) under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health & Care NHS Foundation Trust.

Please can you provide us with the following:

A. The number of memory assessment services that you operate.

B. The area covered by each of these memory assessment services.

For each individual memory assessment service you operate:

1. The service’s annual funding for each of the years 2018-2024 inclusive.

2. The source/s of funding for the service for each of the years 2018-2024 inclusive.

3. The total annual number of patients seen by the service for each of the years 2018-2024 inclusive.

I would like to determine the number of NHS Mental Health Trusts that offer Animal Assisted Therapy to their patients.

I would also like to know how much is spent by the Mental Health Trusts on Animal Assisted Therapies each year.

Finally I would like to know who conducts the animal assisted interventions, is it NHS clinicians or teams brought in specifically to conduct the intervention.

1. Please identify the Talking Therapies service that you are answering on behalf of.
2. Please may you inform us whether Body Dysmorphic Disorder (BDD) appears on your drop-down menu as a diagnosis/ problem descriptor on for example
IAPTus or PC-MIS software for measuring outcomes? (If not, what descriptor, do you use?)
3. If it is not on the drop-down menu, can you identify people with BDD in a different way (for example, the number who have completed the Body Image Questionnaire for BDD)?  
4. Do you use a digital front door like Limbic to screen clients? If yes, which one do you use, and does it directly screen for BDD?
5. Please inform us whether your staff ask the recommended screening question to help identify people with BDD? (The “Talking Therapies manual for anxiety and depression” recommends a question “Have you worried a lot about your appearance or the way a bodily feature looked and wish you could think about it less?”. ) If you do not use the recommended question, do you routinely screen for BDD with a different question or leave it up to therapists to identify if it appears clinically relevant? (if yes, what is the question)?
6. If you use a screening question to try to identify people with BDD, at what stage do you ask the question. e.g., (a) first contact/triage, (b) at assessment at step 2 guided self-help (c) at assessment for step 3 (high intensity)?
7. Please inform us if you use the recommended Anxiety Disorder Specific Measure (ADSM) “The Body Image Questionnaire” (BIQ) in people with BDD to determine outcomes during therapy?  If not, do you use the PHQ9 and GAD7 for BDD or something else?
8. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the total number of people you discharged (all diagnoses, at least one contact) and the total number of people discharged for BDD as the main problem.
9. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the total number of people you took on for therapy (all diagnoses, at least 2 contacts) and the total number of people with BDD that you took on for therapy (at least 2 contacts) that were discharged.
10. Of those that you took on for therapy, what proportion / numbers of people with BDD received treatment at Step 2 with a PWP? If treatment is with a PWP, what proportion and number is a generic CBT for anxiety/ depression or other approach, and what proportion and number received a specific computer program or workbook for BDD?  Please specify which one you use.
11. Of those with BDD who received treatment at Step 2 with a PWP, what was the average number of sessions for generic CBT for anxiety/ depression and for a specific computer program or workbook for BDD?
12. For people discharged from the 1st April 2023 to 31st March 2024 with the last treatment type being step 3, what was the average number of sessions in the episode for those treated with BDD and the average for all other diagnoses in the service?
13. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the number of people with BDD who had 2 Body Image Questionnaires completed prior to discharge (and the number who had the GAD7 instead of the BIQ) at Step 2 and at Step 3 (high intensity)?
14. For people discharged in the year 1st April 2023 – 31st March 2024, what percentage and number of people with BDD in the treated sample achieve reliable improvement at Step 2 and Step 3? (Note the reliable change on the BIQ is ≥10 – please state if you are using the GAD7 for reliable improvement). How does that compare to the percentage and number who achieve reliable improvement on all the other diagnoses in the service?
15. For people discharged in the year 1st April 2023 – 31st March 2024, what was the mean and standard deviation and number of clients of the Body Image Questionnaire in those taken on for treatment at Step 2 and at Step 3?
16. For people discharged in the year 1st April 2023 – 31st March 2024, what was the mean and standard deviation and number of clients with BDD on the Body Image Questionnaire after treatment at Step 2 and at Step 3?
17. For people discharged in the year 1st April 2023 – 31st March 2024, what proportion and number achieve reliable improvement and recovery after treatment (≤ 40 is no longer a case) with BDD on the Body Image Questionnaire at Step 2 and Step 3?
18. How many of your CBT therapists have attended a top up workshop or any other training in treating BDD?
19. Please can you do a survey of your CBT therapists in your service and ask them.  
“How much of a priority do you think is training in BDD compared to other problems in your service?”
1. – Not a priority 
2. – Low priority 
3. – Medium priority
4. – High priority
5. – Essential 

1 (a) In the last 12 months (of data), in total how many patients with Schizophrenia and other non-mood disorders (F20-F29 inclusive) were managed by your Trust.
1 (b) In the last 12 months (of data), in total how many patients diagnosed Schizophrenia (F20 only) were managed by your Trust.

2 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders have been treated within each of the following services:
• Early Intervention Psychosis service team
• Community Mental Health Team

2 (b) In the last 3 months (of data), how many patients with Schizophrenia had no change to the antipsychotic medication within each of the following services. This includes patients with no change in dose.
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged to primary care from each of the following services?
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (b) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged from the Early Intervention Psychosis service team to the Community Mental Health Team

1. The number of individuals who have received support or counselling related to fireworks (e.g., anxiety, trauma, or phobias triggered by fireworks).

2. The data categorised by:
1. Age
2. Gender
3. Year (2021, 2022, 2023, and 2024).
4. Month
5. If possible, broken down by condition:
i. Anxiety, Trauma, Depression, PTSD, Phobia, Ligyrophobia (also spelled Ligurophobia or Phonophobia).

Freedom of Information Request – Ref: 184-2024 Thank you for your recent Freedom of Information...